Financial statements Tb Development
Cash inflows of TB DEVELOPMENT
Year
|
2021
|
2022
|
2023
|
---|---|---|---|
Net cash from operating expenses | -28 646 443,28 | 5 727 344,42 | 17 504 678,31 |
Net cash flow from investing activities | -10 000 000,00 | 0,00 | 0,00 |
Net cash flow from financial activities | 38 715 000,00 | -5 770 000,00 | -12 563 489,33 |
Total net cash flow | 68 556,72 | -42 655,58 | 4 941 188,98 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.